Onesource Specialty Pharma is a finished-dose manufacturer based in India. It appears in 17 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA, ARCSA (EC) and JFDA (JO). Its GMP standing is certified by EMA, ANVISA (Brazil) and US FDA. Its most recent recorded inspection, by US FDA, closed on 28 March 2025 as VAI. Customs aggregates show $313 of exports covering 11 molecules to 5 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Bengaluru, India | 3003813519 |
| Bengaluru, India | 3005652193 |
| Bengaluru Rural, India | 3017501030 |
| BANGALORE, India | Not on file |
| Bommasandra, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 10 | 2 |
| ARCSA (EC) | 5 | None |
| JFDA (JO) | 2 | None |
| EMA | None | 7 |
| ANVISA (Brazil) | None | 6 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $3.9M | 13 |
| 2025 | Not reported | $313 | 5 |
| 2024 | Not reported | $10 | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Onesource Specialty Pharma comes back tiered against every other supplier able to file there.
Start for free